Prostate Cancer

Top Story

Rising PSA contributes to lack of clarity in nonmetastatic prostate cancer

March 22, 2019
In the Journals

Genomic alterations in prostate cancer could help define disease risk

March 10, 2019
Chromosomal alterations could potentially identify men with low-risk prostate cancer detected by needle biopsy who have higher-risk disease in their prostate glands…
In the Journals

BRCA2 mutations linked to worse outcomes, treatment responses in aggressive prostate cancer

March 8, 2019
Germline mutations in the BRCA2 gene have an adverse effect on metastatic castration-resistant prostate cancer outcomes that could be modified by the type of initial…
FDA News

FDA grants breakthrough device designation to artificial intelligence technology for cancer diagnosis

March 7, 2019
The FDA granted breakthrough device designation to Paige.AI, a computational pathology start-up focused on developing
More Headlines »
CME

Clinical Advances in Cutaneous T-cell Lymphoma: What You Need to Know About a Rare Malignancy

This activity is supported by an educational grant from Kyowa Kirin, Inc.

Cutaneous T-cell lymphoma (CTCL) is a rare and heterogeneous type of T-cell lymphoma that is often challenging to…
More »
Video
Meeting News

VIDEO: Anti-CD47 fusion protein well tolerated by patients with solid tumors, non-Hodgkin lymphoma

June 24, 2018
More »
CME

Sickle Cell Disease Forum: Innovation in Drug Development and Emerging Science

This activity is supported by an educational grant from Global Blood Therapeutics.

Sickle cell disease (SCD) is an inherited molecular condition whose clinical severity has extreme phenotypic…
More »